Oluchi Judith Osuala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Oluchi Judith Osuala has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Chinyere Constance Ezemba
Chukwuemeka Odumegwu Ojukwu University; Chychy Gilgal Limited
5 shared publications A. S. Ezemba
3 shared publications- Charles Okeke Nnadi
Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka 410001, Nigeria
2 shared publications Chukwemeka Chukwuma
2 shared publicationsVictor Etikudike
2 shared publicationsAnastecia Okpe-Ezeamalu
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2026 (1) , 5663176
Mechanisms, Significance, Detection and Emerging Therapies for Carbapenem‐Resistant Enterobacterales: A Scoping Review
Background: Carbapenems are among the most important broad‐spectrum β‐lactam antibiotics for the treatment of severe infections caused by multi–drug‐resistant Gram‐negative bacteria. However, the global emergence and dissemination of carbapenem‐resistant Enterobacterales (CRE), particularly carbapenemase‐producing Enterobacterales (CPE), have significantly compromised their clinical utility. Resistance is primarily driven by the acquisition of genes encoding carbapenemases, often in combination with porin alterations, efflux pump overexpression and AmpC hyperproduction, resulting in limited treatment options and increased morbidity and mortality. Objectives: This scoping review aimed to synthesise current evidence on the molecular mechanisms of carbapenem resistance, the classification and epidemiology of carbapenemases, advances in diagnostic approaches and emerging therapeutic strategies for CRE infections. Methods: A scoping review was conducted in accordance with the PRISMA extension for Scoping Reviews (PRISMA‐ScR). Literature published between January 2005 and March 2026 was identified through systematic searches of PubMed/MEDLINE, Scopus and Google Scholar. Eligible studies included original research articles, surveillance reports, systematic reviews and clinical guidelines addressing carbapenem resistance mechanisms, carbapenemase epidemiology, diagnostics or treatment strategies. Data were extracted and synthesised using a narrative and thematic approach. Results: Carbapenemase production was identified as the predominant mechanism of resistance among CRE, with KPC, NDM, OXA‐48‐like, VIM and IMP enzymes driving global dissemination. Considerable geographical variation exists in carbapenemase distribution, reflecting differences in antimicrobial use, surveillance capacity and healthcare infrastructure. Advances in molecular diagnostics, including polymerase chain reaction, loop‐mediated isothermal amplification, whole‐genome sequencing and rapid immunochromatographic assays, have improved detection and surveillance. Emerging therapeutic options, particularly novel β‐lactam/β‐lactamase inhibitor combinations and cefiderocol, have expanded treatment possibilities, although resistance to newer agents continues to emerge. Conclusions: CREs remain a major global public health threat. Strengthened surveillance systems, improved access to rapid diagnostics, carbapenemase‐directed therapeutic strategies and continued antimicrobial development are essential to limit the spread of resistance and improve clinical outcomes.
- 1 January 2026
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2026 (1) , 5663176
Open AccessMechanisms, Significance, Detection and Emerging Therapies for Carbapenem‐Resistant Enterobacterales: A Scoping Review
Background: Carbapenems are among the most important broad‐spectrum β‐lactam antibiotics for the treatment of severe infections caused by multi–drug‐resistant Gram‐negative bacteria. However, the global emergence and dissemination of carbapenem‐resistant Enterobacterales (CRE), particularly carbapenemase‐producing Enterobacterales (CPE), have significantly compromised their clinical utility. Resistance is primarily driven by the acquisition of genes encoding carbapenemases, often in combination with porin alterations, efflux pump overexpression and AmpC hyperproduction, resulting in limited treatment options and increased morbidity and mortality. Objectives: This scoping review aimed to synthesise current evidence on the molecular mechanisms of carbapenem resistance, the classification and epidemiology of carbapenemases, advances in diagnostic approaches and emerging therapeutic strategies for CRE infections. Methods: A scoping review was conducted in accordance with the PRISMA extension for Scoping Reviews (PRISMA‐ScR). Literature published between January 2005 and March 2026 was identified through systematic searches of PubMed/MEDLINE, Scopus and Google Scholar. Eligible studies included original research articles, surveillance reports, systematic reviews and clinical guidelines addressing carbapenem resistance mechanisms, carbapenemase epidemiology, diagnostics or treatment strategies. Data were extracted and synthesised using a narrative and thematic approach. Results: Carbapenemase production was identified as the predominant mechanism of resistance among CRE, with KPC, NDM, OXA‐48‐like, VIM and IMP enzymes driving global dissemination. Considerable geographical variation exists in carbapenemase distribution, reflecting differences in antimicrobial use, surveillance capacity and healthcare infrastructure. Advances in molecular diagnostics, including polymerase chain reaction, loop‐mediated isothermal amplification, whole‐genome sequencing and rapid immunochromatographic assays, have improved detection and surveillance. Emerging therapeutic options, particularly novel β‐lactam/β‐lactamase inhibitor combinations and cefiderocol, have expanded treatment possibilities, although resistance to newer agents continues to emerge. Conclusions: CREs remain a major global public health threat. Strengthened surveillance systems, improved access to rapid diagnostics, carbapenemase‐directed therapeutic strategies and continued antimicrobial development are essential to limit the spread of resistance and improve clinical outcomes.
- Open Access
- 1 January 2025
- Published by Elsevier in SSRN Electronic Journal
Antimicrobial Activity of Curry Leaf (Murraya keonigii) Extracts: An In-Vitro Study
Curry leaves, scientifically referred to as Murraya koenigii, are well known for their aromatic taste in foods, but their antimicrobial potential has yet to be extensively studied. This study aimed to determine the antibacterial effect of curry leaf extracts against various microorganisms. The study involved the extraction of bioactive compounds from curry leaves using aqueous and ethanol solvents. Antimicrobial susceptibility testing was performed using agar well diffusion to establish the impact of the extracts on microbial isolates, including Salmonella sp, Bacillus sp, Escherichia coli, Candida albicans, and Staphylococcus aureus. Gas Chromatography-Mass Spectrometry (GC-MS) was used to analyse the extracts' chemical components. Although their effectiveness against microbiological isolates varied, it was shown that both ethanol and aqueous extracts have antibacterial properties. Inhibition against Salmonella sp., Bacillus sp., Staphylococcus aureus, Candida albicans, and Escherichia coli, the ethanol extract's Minimum Inhibitory Concentration (MIC) was 100 mg/ml, 25 mg/ml, 0, 100 mg/ml, and 100 mg/ml, respectively. The aqueous extract exhibited MIC values of 200 mg/mL against Bacillus sp. and Candida albicans, 25 mg/mL against Salmonella sp., and 12.5 mg/mL against Escherichia coli. As for Staphylococcus aureus, it was not inhibited. A minimum bactericidal concentration (MBC) of 50 mg/ml of ethanol extract was found for Bacillus sp, Salmonella sp, and 100 mg/ml for Candida albicans. Having no bactericidal effect against Staphylococcus aureus, the aqueous extract showed MBC of 200 mg/ml against Bacillus sp. and Candida albicans, 100 mg/ml against Salmonella sp., and 25 mg/ml against Escherichia coli. Compounds such as Hexadecanoic acid, Phytol, Octadecanoic acid among others were detected from the extracts. The study points to the therapeutic potential of curry leaves as natural antibacterials.
- 1 January 2025
- Published by Elsevier in SSRN Electronic Journal
Open AccessAntimicrobial Activity of Curry Leaf (Murraya keonigii) Extracts: An In-Vitro Study
Curry leaves, scientifically referred to as Murraya koenigii, are well known for their aromatic taste in foods, but their antimicrobial potential has yet to be extensively studied. This study aimed to determine the antibacterial effect of curry leaf extracts against various microorganisms. The study involved the extraction of bioactive compounds from curry leaves using aqueous and ethanol solvents. Antimicrobial susceptibility testing was performed using agar well diffusion to establish the impact of the extracts on microbial isolates, including Salmonella sp, Bacillus sp, Escherichia coli, Candida albicans, and Staphylococcus aureus. Gas Chromatography-Mass Spectrometry (GC-MS) was used to analyse the extracts' chemical components. Although their effectiveness against microbiological isolates varied, it was shown that both ethanol and aqueous extracts have antibacterial properties. Inhibition against Salmonella sp., Bacillus sp., Staphylococcus aureus, Candida albicans, and Escherichia coli, the ethanol extract's Minimum Inhibitory Concentration (MIC) was 100 mg/ml, 25 mg/ml, 0, 100 mg/ml, and 100 mg/ml, respectively. The aqueous extract exhibited MIC values of 200 mg/mL against Bacillus sp. and Candida albicans, 25 mg/mL against Salmonella sp., and 12.5 mg/mL against Escherichia coli. As for Staphylococcus aureus, it was not inhibited. A minimum bactericidal concentration (MBC) of 50 mg/ml of ethanol extract was found for Bacillus sp, Salmonella sp, and 100 mg/ml for Candida albicans. Having no bactericidal effect against Staphylococcus aureus, the aqueous extract showed MBC of 200 mg/ml against Bacillus sp. and Candida albicans, 100 mg/ml against Salmonella sp., and 25 mg/ml against Escherichia coli. Compounds such as Hexadecanoic acid, Phytol, Octadecanoic acid among others were detected from the extracts. The study points to the therapeutic potential of curry leaves as natural antibacterials.
- Open Access
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Evaluation of Antimicrobial Effects of Chromolaena Odorata Extracts on Microbial Isolates
As science and technology advanced, antimicrobial agents were discovered, bringing with them the burden of antimicrobial resistance. This led to the hunt for effective techniques to combat microbial diseases. Chromolaena odorata is often used for traditional wound healing since it helps to stop bleeding quickly. Chromolaena odorata of the Asteraceae family is one of the world's most invasive weeds. It is also known as Siam weed, devil weed, French weed, communist weed, hagonoy, co chon triffid weed, and Awolowo, Akintola, and Obiarakara weed. Chromolaena odorata is often used for traditional wound healing since it helps to stop bleeding quickly. Several studies have shown that Siam weed extract promotes hemostasis and wound healing. The purpose of this research is to evaluate the bioactive components and antibacterial efficacy of different extracts of Chromolaena odorata on various microbiological isolates. Fresh leaves were collected, identified, air-dried, and ground. Cold maceration and soxhlet extraction were carried out using ethanol and n-hexane as extractive solvents, respectively. The chemical composition was identified using the gas chromatography-mass spectrometry technique, and the antibacterial action was tested using established protocols. The antimicrobial test revealed that the aqueous extract had a bacteriostatic effect, but the ethanol extract had a bactericidal effect against microbiological isolates at a concentration of 200mg/mL. The most prevalent bioactive chemicals discovered in both extracts are oleic acid, octadecanoic acid, and hexadecanoic acid. The extracts possessed antibacterial capabilities and included certain bioactive components, which might contribute to their overall efficacy, according to this research.
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Open AccessEvaluation of Antimicrobial Effects of Chromolaena Odorata Extracts on Microbial Isolates
As science and technology advanced, antimicrobial agents were discovered, bringing with them the burden of antimicrobial resistance. This led to the hunt for effective techniques to combat microbial diseases. Chromolaena odorata is often used for traditional wound healing since it helps to stop bleeding quickly. Chromolaena odorata of the Asteraceae family is one of the world's most invasive weeds. It is also known as Siam weed, devil weed, French weed, communist weed, hagonoy, co chon triffid weed, and Awolowo, Akintola, and Obiarakara weed. Chromolaena odorata is often used for traditional wound healing since it helps to stop bleeding quickly. Several studies have shown that Siam weed extract promotes hemostasis and wound healing. The purpose of this research is to evaluate the bioactive components and antibacterial efficacy of different extracts of Chromolaena odorata on various microbiological isolates. Fresh leaves were collected, identified, air-dried, and ground. Cold maceration and soxhlet extraction were carried out using ethanol and n-hexane as extractive solvents, respectively. The chemical composition was identified using the gas chromatography-mass spectrometry technique, and the antibacterial action was tested using established protocols. The antimicrobial test revealed that the aqueous extract had a bacteriostatic effect, but the ethanol extract had a bactericidal effect against microbiological isolates at a concentration of 200mg/mL. The most prevalent bioactive chemicals discovered in both extracts are oleic acid, octadecanoic acid, and hexadecanoic acid. The extracts possessed antibacterial capabilities and included certain bioactive components, which might contribute to their overall efficacy, according to this research.
- Open Access
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Antimicrobial Analysis of Traditional and Industrial Produced Vinegar
The vinegar produced from different locally grown fruits and industrial produced vinegar was evaluated to determine its antimicrobial properties. Agar well diffusion method was used for this analysis. The antimicrobial activities of both locally and industrially produced vinegar were identified using different microbial isolates which includes Escherichia coli, Staphylococcus aureus and Candida sp using different extracts of the vinegar.The results of the antimicrobial analysis showed that the vinegar exhibit different activities on the clinical isolates. Concentrations of 500mg/ml, 250mg/ml, 125mg/ml and 62.5mg/ml of the vinegar extracts were used. The aqueous and n-butanol extract of Vin A gave the highest zone of inhibition with a diameter of 19mm on Staphylococcus aureus at 500mg/ml concentration.The aqueous extract of Vin A gave diameter range of 15mm-19mm for S. aureus and 11mm-17mm for Candida sp. n-Butanol extract gave the range of 10mm-12mm for E.coli, 12mm-19mm on S. aureus and 7mm-15mm onCandida sp. The ethyl acetate of Vin A gave a diameter of 9mm and 10mm for Candida sp. The n-Butanol extract of Vin B gave the diameter of 10mm for E.coliat 500mg/ml, 6mm and 60mm for S. aureus and 9mm for Candida sp. the aqueous extract of Vin C gave diameter of ranges within 8mm-11mm for E.coli, and 10mm on cCandida sp. The n-Butanol extract gave the range of 7mm-10mm on E.coli, 8mm-12mm on S. aureus and 9-10mm on Candida sp. n-butanol extract of Vin D gave a diameter of 9mm for E.coli, 10mm for staph and a diameter range of 7-11mm for Candida sp. The ethylacetate of the extract gave 7mm and 8mm for E.coli, 9mm and 11mm for Candida sp. The vinegars analysed exhibited bactericidal, bacteriostatic and no activity on the clinical isolates.
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Open AccessAntimicrobial Analysis of Traditional and Industrial Produced Vinegar
The vinegar produced from different locally grown fruits and industrial produced vinegar was evaluated to determine its antimicrobial properties. Agar well diffusion method was used for this analysis. The antimicrobial activities of both locally and industrially produced vinegar were identified using different microbial isolates which includes Escherichia coli, Staphylococcus aureus and Candida sp using different extracts of the vinegar.The results of the antimicrobial analysis showed that the vinegar exhibit different activities on the clinical isolates. Concentrations of 500mg/ml, 250mg/ml, 125mg/ml and 62.5mg/ml of the vinegar extracts were used. The aqueous and n-butanol extract of Vin A gave the highest zone of inhibition with a diameter of 19mm on Staphylococcus aureus at 500mg/ml concentration.The aqueous extract of Vin A gave diameter range of 15mm-19mm for S. aureus and 11mm-17mm for Candida sp. n-Butanol extract gave the range of 10mm-12mm for E.coli, 12mm-19mm on S. aureus and 7mm-15mm onCandida sp. The ethyl acetate of Vin A gave a diameter of 9mm and 10mm for Candida sp. The n-Butanol extract of Vin B gave the diameter of 10mm for E.coliat 500mg/ml, 6mm and 60mm for S. aureus and 9mm for Candida sp. the aqueous extract of Vin C gave diameter of ranges within 8mm-11mm for E.coli, and 10mm on cCandida sp. The n-Butanol extract gave the range of 7mm-10mm on E.coli, 8mm-12mm on S. aureus and 9-10mm on Candida sp. n-butanol extract of Vin D gave a diameter of 9mm for E.coli, 10mm for staph and a diameter range of 7-11mm for Candida sp. The ethylacetate of the extract gave 7mm and 8mm for E.coli, 9mm and 11mm for Candida sp. The vinegars analysed exhibited bactericidal, bacteriostatic and no activity on the clinical isolates.
- Open Access
- 1 January 2023
- Published by Elsevier in SSRN Electronic Journal
Antimicrobial Effect of Cinnamon Bark Extracts on Microbial Isolates
The use of plant extracts and phytochemicals, both with known antimicrobial properties, can be of great significance in therapeutic treatments. The aim of this study is to evaluate the antimicrobial activity of Cinnamomum zeylanicum (cinnamon) stick/bark extract on microbial isolates. The cinnamon barks were grounded and divided into two, one was macerated in ethanol and the other was macerated in water for 72hrs. The extract was tested for its antimicrobial effect on Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus sp and Candida albicans using agar well diffusion methods. GC-MS was carried out to determine its bioactive compounds. For the ethanol extract, 200mg/ml had the highest zone of inhibition for S. aureus, P. aeruginosa. Bacillus sp and Candida albicans with 9.50mm, 14mm, 19.50mm, 18mm respectively and the highest for E. coli was 25 mg/ml at 8.80mm. The lowest zones of inhibition was found at 6.26mg/ml for all isolates. For the aqueous extract, 200mg/ml had the highest zone of inhibition and the lowest was found in 6.25mg/ml for all isolates. The minimum inhibitory concentration for all the organism for both the aqueous and the ethanol extracts is 25mg/ml. There is no bactericidal action for the aqueous extract but for the ethanol extract, 200mg/ml was the minimum bactericidal concentration for E. coli, P. aeruginosa and S. aureus while 100mg/ml was the minimum bactericidal concentration for Bacillus sp., and Candida sp. In the aqueous extract, 2H-1-Benzopyran-2-one-4-diethylphosphonate was found to be the most abundant compound with a percentage area of 28.09%. In the ethanol extract, Octamethylcyclotetrasiloxane and, Dodecamethylpentasiloxane were found to be the most abundant compounds with percentage areas of 10.98% and 6.64% respectively. From the results presented, it showed that cinnamon barks have antimicrobial properties and also certain compounds that have been reported to contribute to its properties.
- 1 January 2023
- Published by Elsevier in SSRN Electronic Journal
Open AccessAntimicrobial Effect of Cinnamon Bark Extracts on Microbial Isolates
The use of plant extracts and phytochemicals, both with known antimicrobial properties, can be of great significance in therapeutic treatments. The aim of this study is to evaluate the antimicrobial activity of Cinnamomum zeylanicum (cinnamon) stick/bark extract on microbial isolates. The cinnamon barks were grounded and divided into two, one was macerated in ethanol and the other was macerated in water for 72hrs. The extract was tested for its antimicrobial effect on Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus sp and Candida albicans using agar well diffusion methods. GC-MS was carried out to determine its bioactive compounds. For the ethanol extract, 200mg/ml had the highest zone of inhibition for S. aureus, P. aeruginosa. Bacillus sp and Candida albicans with 9.50mm, 14mm, 19.50mm, 18mm respectively and the highest for E. coli was 25 mg/ml at 8.80mm. The lowest zones of inhibition was found at 6.26mg/ml for all isolates. For the aqueous extract, 200mg/ml had the highest zone of inhibition and the lowest was found in 6.25mg/ml for all isolates. The minimum inhibitory concentration for all the organism for both the aqueous and the ethanol extracts is 25mg/ml. There is no bactericidal action for the aqueous extract but for the ethanol extract, 200mg/ml was the minimum bactericidal concentration for E. coli, P. aeruginosa and S. aureus while 100mg/ml was the minimum bactericidal concentration for Bacillus sp., and Candida sp. In the aqueous extract, 2H-1-Benzopyran-2-one-4-diethylphosphonate was found to be the most abundant compound with a percentage area of 28.09%. In the ethanol extract, Octamethylcyclotetrasiloxane and, Dodecamethylpentasiloxane were found to be the most abundant compounds with percentage areas of 10.98% and 6.64% respectively. From the results presented, it showed that cinnamon barks have antimicrobial properties and also certain compounds that have been reported to contribute to its properties.